Maksymowych WP - Search Results

1

Canadian recommendations for clinical trials of pharmacologic interventions in rheumatoid arthritis: inclusion criteria and study design.

Karsh J, Keystone EC, Haraoui B, Thorne JC, Pope JE, Bykerk VP, Maksymowych WP, Zummer M, Bensen WG, Kraishi MM; Canadian Rheumatology Research Consortium. Karsh J, et al. Among authors: maksymowych wp. J Rheumatol. 2011 Oct;38(10):2095-104. doi: 10.3899/jrheum.110188. Epub 2011 Jul 15. J Rheumatol. 2011. PMID: 21765109 Free article. Review.

2

An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis.

Maksymowych WP, Avina-Zubieta A, Luong MH, Russell AS. Maksymowych WP, et al. J Rheumatol. 1995 Apr;22(4):625-9. J Rheumatol. 1995. PMID: 7791152 Clinical Trial.

3

High dose intravenous immunoglobulin (IVIg) in severe refractory rheumatoid arthritis: no evidence for efficacy.

Maksymowych WP, Aviña-Zubieta A, Luong M, Russell AS. Maksymowych WP, et al. Clin Exp Rheumatol. 1996 Nov-Dec;14(6):657-60. Clin Exp Rheumatol. 1996. PMID: 8978962 Clinical Trial.

4

Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.

Maksymowych WP, Lambert R, Jhangri GS, Leclercq S, Chiu P, Wong B, Aaron S, Russell AS. Maksymowych WP, et al. J Rheumatol. 2001 Jan;28(1):144-55. J Rheumatol. 2001. PMID: 11196517 Clinical Trial.

5

A randomized, placebo controlled trial of an antisense oligodeoxynucleotide to intercellular adhesion molecule-1 in the treatment of severe rheumatoid arthritis.

Maksymowych WP, Blackburn WD Jr, Tami JA, Shanahan WR Jr. Maksymowych WP, et al. J Rheumatol. 2002 Mar;29(3):447-53. J Rheumatol. 2002. PMID: 11908555 Clinical Trial.

6

HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis.

Maksymowych WP, Suarez-Almazor ME, Buenviaje H, Cooper BL, Degeus C, Thompson M, Russell AS. Maksymowych WP, et al. J Rheumatol. 2002 Nov;29(11):2319-26. J Rheumatol. 2002. PMID: 12415587

7

The responsiveness of generic health status measures as assessed in patients with rheumatoid arthritis receiving infliximab.

Russell AS, Conner-Spady B, Mintz A, Maksymowych WP. Russell AS, et al. Among authors: maksymowych wp. J Rheumatol. 2003 May;30(5):941-7. J Rheumatol. 2003. PMID: 12734886

8

Canadian Rheumatology Association Consensus on the use of anti-tumor necrosis factor-alpha directed therapies in the treatment of spondyloarthritis.

Maksymowych WP, Inman RD, Gladman D, Thomson G, Stone M, Karsh J, Russell AS; Spondyloarthritis Research Consortium of Canada (SPARCC). Maksymowych WP, et al. J Rheumatol. 2003 Jun;30(6):1356-63. J Rheumatol. 2003. PMID: 12784417 Review.

9

The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada.

Gladman DD, Cook RJ, Schentag C, Feletar M, Inman RI, Hitchon C, Karsh J, Klinkhoff AV, Maksymowych WP, Mosher DP, Nair B, Stone MA. Gladman DD, et al. Among authors: maksymowych wp. J Rheumatol. 2004 Jun;31(6):1126-31. J Rheumatol. 2004. PMID: 15170925

10

Mandatory pharmacosurveillance--a Canadian model for access to therapy and research.

Barr SG, Martin L, Chung C, Maksymowych WP. Barr SG, et al. Among authors: maksymowych wp. Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S39-43. Clin Exp Rheumatol. 2004. PMID: 15552513 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters